Introduction
Sphingolipid metabolism is a highly controlled process that is involved in regulating bioactive lipid signaling pathways and serves important roles in several cellular processes in breast cancer. Invasive ductal carcinoma (IDC), which is characterized by the malignant proliferation of the ductal epithelium and stromal invasion, is the most common type of breast cancer. Recent advances in genetic research have accelerated the discovery of novel prognostic factors and therapeutic targets for the disease. The aim of the present study was to investigate the expression and prognostic significance of sphingolipid metabolism-related genes in female IDC.
Methods
The present study used gene expression RNAseq data obtained from The Cancer Genome Atlas breast invasive carcinoma (TCGA BRCA) datasets.
Results
Sphingolipid metabolism-related genes exhibited dysregulated mRNA expression levels in IDC. The Student’s
t
-test revealed that
SMPDL3B, B4GALNT1, LPAR2
, and
LASS2
were significantly upregulated, while
LASS3, LPAR1, B4GALT6, GAL3ST1, HPGD, ST8SIA1, UGT8
, and
S1PR1
were significantly downregulated in female IDC tissues compared with normal solid tissues. Kaplan–Meier survival analyses revealed that high
SMPDL3B
mRNA expression levels were associated with good prognosis in female IDC, suggesting that
SMPDL3B
plays a tumor suppressor role. To the best of our knowledge, the present study was the first to report that dysregulated expressions of
SMPDL3B
are significantly associated with age, estrogen receptor status, progesterone receptor status, and histological subtype.
Conclusion
Taken together, our study indicated that
SMPDL3B
may have a pathophysiological role and serve as a novel prognostic biomarker in IDC.